Our estimate of APOE-ε4-associated risk for AD+LB+ pathology is in line with the estimate in Kaivola et al., the next largest study of pathologically assessed individuals (OR = 4.25, P = 1. The gene discussed is APOE; the disease is Alzheimer disease.